Longitudinal Corneal Endothelial Cell Changes in Patients Undergoing Hematopoietic Stem Cell Transplantation

被引:7
作者
Pellegrini, Marco [1 ,2 ]
Giannaccare, Giuseppe [3 ]
Bernabei, Federico [1 ,2 ]
Moscardelli, Fabiana [1 ,2 ]
Sessa, Mariarosaria [2 ,4 ]
Arpinati, Mario [2 ,4 ]
Bonifazi, Francesca [1 ,2 ]
Versura, Piera [1 ,2 ]
机构
[1] Univ Bologna, Alma Mater Studiorum, Ophthalmol Unit, DIMES, Bologna, Italy
[2] S Orsola Malpighi Teaching Hosp, Bologna, Italy
[3] Magna Graecia Univ Catanzaro, Dept Ophthalmol, Catanzaro, Italy
[4] Univ Bologna, Hematol Unit, DIMES, Alma Mater Studiorum, Bologna, Italy
关键词
hematopoietic stem cell transplantation; ocular graft versus host disease; corneal endothelium; GVHD; dry eye; VERSUS-HOST-DISEASE;
D O I
10.1097/ICO.0000000000002441
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate longitudinally corneal endothelial cell changes in patients undergoing hematopoietic stem cell transplantation (HSCT) and to further investigate possible correlations with hematological and ocular characteristics. Methods: Prospective observational study conducted at a single center. All patients underwent a comprehensive ophthalmological examination, before and after HSCT, including slitlamp examination, Schirmer test, tear breakup time, ocular surface staining, specular microscopy of corneal endothelium, and Ocular Surface Disease Index questionnaire. Results: Twenty-five patients undergoing HSCT and 25 age- and sex-matched controls were included. At baseline, hematological patients showed significantly lower values of endothelial cell density (ECD) compared with those of controls (2514.5 +/- 390.2 vs. 2723.7 +/- 298.0 cells/mm(2), P = 0.038). After HSCT, ocular surface disease index score significantly increased (P = 0.020) and tear breakup time significantly decreased (P = 0.036). Conversely, no significant changes were found in Schirmer test and corneal fluorescein staining (always P > 0.05). Eight patients (32%) developed ocular graft-versus-host disease (GVHD). ECD values significantly decreased after HSCT (from 2514.5 +/- 390.2 to 2409.5 +/- 330.9 cells/mm(2), P = 0.009). The decrease in ECD values after HSCT was more pronounced in patients with ocular GVHD compared with those without (231.1 +/- 188.8 vs. 45.6 +/- 156.5, P = 0.016). No significant correlations between the changes in ECD and hematological and ocular characteristics were found (always P > 0.05). Conclusions: Hematological patients showed a lower endothelial cell count already before HSCT, compared with controls. After HSCT, the endothelial cell count further significantly decreased, particularly in patients who developed ocular GVHD.
引用
收藏
页码:462 / 466
页数:5
相关论文
共 50 条
[41]   Endothelial Function in Patients with Hematologic Malignancies Undergoing High-Dose Chemotherapy Followed by Hematopoietic Stem Cell Transplantation [J].
Małgorzata Poręba ;
Paweł Gać ;
Lidia Usnarska-Zubkiewicz ;
Witold Pilecki ;
Kazimierz Kuliczkowski ;
Grzegorz Mazur ;
Małgorzata Sobieszczańska ;
Rafał Poręba .
Cardiovascular Toxicology, 2016, 16 :156-162
[42]   Gut microbiome in children undergoing hematopoietic stem cell transplantation [J].
Jozefczuk, Pawel ;
Bilinski, Jaroslaw ;
Minkowska, Aleksandra ;
Laguna, Pawel .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2024, 72
[43]   Quality of Life of Sickle Cell Disease Patients After Hematopoietic Stem Cell Transplantation: a Longitudinal Study [J].
dos Santos Lotério L. ;
de Oliveira-Cardoso É.A. ;
Simões B.P. ;
de Oliveira M.C. ;
Garcia J.T. ;
Guimarães A.L.C. ;
Pereira K.C. ;
Costa T.C.M. ;
Cunha R.L.G. ;
dos Santos M.A. .
Trends in Psychology, 2022, 30 (3) :513-527
[44]   A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation [J].
Nelson, Adam S. ;
Marsh, Rebecca A. ;
Myers, Kasiani C. ;
Davies, Stella M. ;
Jodele, Sonata ;
O'Brien, Tracey A. ;
Mehta, Parinda A. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (05) :884-888
[45]   Tacrolimus in hematopoietic stem cell transplantation [J].
Fortune, Kara ;
Couriel, Daniel .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (07) :835-841
[46]   Pulmonary endothelial chimerism after hematopoietic stem cell transplantation [J].
Kyoko Hijiya ;
Toyofumi Fengshi Chen-Yoshikawa ;
Aya Miyagawa-Hayashino ;
Tadakazu Kondo ;
Akihiro Aoyama ;
Hironori Haga ;
Akifumi Takaori-Kondo ;
Hiroshi Date .
Surgery Today, 2018, 48 :101-109
[47]   Validation of the Disease Risk Index for Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation after T Cell Depletion [J].
Beauverd, Yan ;
Roosnek, Eddy ;
Tirefort, Yordanka ;
Nagy-Hulliger, Monika ;
Bernimoulin, Michael ;
Tsopra, Olga ;
Ansari, Marc ;
Dantin, Carole ;
Casini, Alessandro ;
Grandjean, Anne-Pascale ;
Chigrinova, Ekaterina ;
Masouridi-Levrat, Stavroula ;
Chalandon, Yves .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (09) :1322-1328
[48]   Role of Hematopoietic Stem Cell Transplantation in Patients with Myeloproliferative Disease [J].
Salit, Rachel B. ;
Deeg, H. Joachim .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (06) :1023-+
[49]   Inflammatory Markers in Patients after Hematopoietic Stem Cell Transplantation [J].
Sjoqvist, Camilla ;
Snarski, Emilian .
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2013, 61 (04) :301-307
[50]   Endodontic Treatment in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study [J].
Mota, Maria Emilia ;
Siqueira Jr, Jose F. ;
Rocas, Isabela N. ;
Alves, Fabio Abreu ;
Jaguar, Graziella Chagas ;
Franco, Juliana Bertoldi ;
Schmidt Filho, Jayr ;
Moreira, Maria Stella .
JOURNAL OF ENDODONTICS, 2025, 51 (01) :35-42